8 research outputs found

    Adult populations of each Lao province in 2005 [15].

    No full text
    <p>Adult populations of each Lao province in 2005 <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0044545#pone.0044545-National1" target="_blank">[15]</a>.</p

    Estimated percentage beneficial effect on each infection of individual empirical treatments.

    No full text
    <p>Inclusion threshold: percentage of all febrile cases of diseases treatable by each individual empirical treatment that must be exceeded for the inclusion of that treatment in an empirical protocol.</p

    Graphs illustrating the model predictions of the effect of spatial heterogeneity given the baseline input values in Tables (1, 2, 3).

    No full text
    <p>The mean predicted numbers of appropriate treatments if a protocol based on the Vientiane epidemiology is applied nationally is plotted in Graph (a) for a range of values for national and regional variation. The 2.5% and 97.5% prediction intervals are plotted in Graphs (c) and (e). The mean additional numbers of appropriate treatments (i.e. the potential impact) predicted if a spatially explicit treatment protocol based on the incidence not only in Vientiane but also in three sentinel provinces were applied is plotted in Graph (b) for the same range of national and regional variation. The 2.5% and 97.5% prediction intervals are plotted in Graphs (c) and (f).</p

    Clinical manifestations.

    No full text
    <p>*Percent of DENV-1 cases with ascites.</p><p>†Mean pleural effusion indexes (PEI) were significantly higher among DENV-2 compared to DENV-1.</p><p>‡Mean pleural effusion indexes (PEI) were significantly higher among secondary infections as compared to primary infections.</p

    Serotype-specific data.

    No full text
    <p>Significant differences between study years within a serotype include:</p>*<p>p = 0.05 compared to 2004.</p>**<p>p = 0.02 compared to 2004.</p>†<p>p = 0.03 compared to 2006.</p>‡<p>p = 0.03 compared to 2006. Significant differences in disease severity between study years overall include:</p>§<p>most severe study year is used as reference.</p>##<p>least severe study year is used as reference.</p>#<p>Discrepancies in totals are due to the 7 cases that were not serotyped and the single case that did not receive a serological response profile.</p
    corecore